USD 15.97
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | -4.04 Billion JPY | -117.29% |
2023 | 23.38 Billion JPY | -53.69% |
2022 | 50.49 Billion JPY | 98.84% |
2021 | 25.39 Billion JPY | 155.48% |
2020 | 9.93 Billion JPY | -32.15% |
2019 | 14.64 Billion JPY | -17.0% |
2018 | 17.64 Billion JPY | -37.1% |
2017 | 28.05 Billion JPY | 7.7% |
2016 | 26.05 Billion JPY | -3.56% |
2015 | 27.01 Billion JPY | 1.07% |
2014 | 26.72 Billion JPY | 4.41% |
2013 | 25.59 Billion JPY | 10.26% |
2012 | 23.21 Billion JPY | 8.86% |
2011 | 21.32 Billion JPY | 7.66% |
2010 | 19.8 Billion JPY | 32.66% |
2009 | 14.93 Billion JPY | 0.93% |
2008 | 14.79 Billion JPY | 1.85% |
2007 | 14.52 Billion JPY | 9.36% |
2006 | 13.28 Billion JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 FY | -4.04 Billion JPY | -117.3% |
2024 Q1 | -1.71 Billion JPY | -536.06% |
2024 Q2 | 141 Million JPY | 108.24% |
2024 Q3 | 422 Million JPY | 199.29% |
2024 Q4 | -2.89 Billion JPY | -786.49% |
2023 Q3 | 5.96 Billion JPY | -34.47% |
2023 FY | 23.38 Billion JPY | -53.69% |
2023 Q4 | -269 Million JPY | -104.51% |
2023 Q1 | 8.58 Billion JPY | -40.08% |
2023 Q2 | 9.1 Billion JPY | 6.11% |
2022 Q1 | 12.22 Billion JPY | 59.04% |
2022 Q2 | 14.72 Billion JPY | 20.42% |
2022 FY | 50.49 Billion JPY | 98.84% |
2022 Q3 | 9.22 Billion JPY | -37.38% |
2022 Q4 | 14.31 Billion JPY | 55.3% |
2021 Q1 | 1.12 Billion JPY | -29.31% |
2021 Q4 | 7.68 Billion JPY | -19.56% |
2021 Q3 | 9.55 Billion JPY | 36.12% |
2021 FY | 25.39 Billion JPY | 155.48% |
2021 Q2 | 7.02 Billion JPY | 524.73% |
2020 FY | 9.93 Billion JPY | -32.15% |
2020 Q1 | 3.1 Billion JPY | -5.08% |
2020 Q2 | 2.65 Billion JPY | -14.26% |
2020 Q3 | 2.59 Billion JPY | -2.52% |
2020 Q4 | 1.59 Billion JPY | -38.63% |
2019 Q4 | 3.26 Billion JPY | -25.07% |
2019 Q3 | 4.35 Billion JPY | 21.62% |
2019 FY | 14.64 Billion JPY | -17.0% |
2019 Q1 | 3.43 Billion JPY | 76.63% |
2019 Q2 | 3.58 Billion JPY | 4.22% |
2018 Q2 | 5.7 Billion JPY | -20.81% |
2018 Q4 | 1.94 Billion JPY | -30.27% |
2018 Q1 | 7.2 Billion JPY | 27.5% |
2018 FY | 17.64 Billion JPY | -37.1% |
2018 Q3 | 2.79 Billion JPY | -51.06% |
2017 Q2 | 7.4 Billion JPY | 1.42% |
2017 FY | 28.05 Billion JPY | 7.7% |
2017 Q4 | 5.65 Billion JPY | -26.58% |
2017 Q3 | 7.69 Billion JPY | 3.87% |
2017 Q1 | 7.3 Billion JPY | 34.41% |
2016 Q2 | 7.11 Billion JPY | 6.96% |
2016 Q1 | 6.65 Billion JPY | 18.59% |
2016 Q4 | 5.43 Billion JPY | -20.64% |
2016 Q3 | 6.84 Billion JPY | -3.78% |
2016 FY | 26.05 Billion JPY | -3.56% |
2015 Q1 | 7.13 Billion JPY | 23.13% |
2015 FY | 27.01 Billion JPY | 1.07% |
2015 Q4 | 5.61 Billion JPY | -18.54% |
2015 Q3 | 6.88 Billion JPY | -6.64% |
2015 Q2 | 7.37 Billion JPY | 3.35% |
2014 Q4 | 5.79 Billion JPY | -12.64% |
2014 FY | 26.72 Billion JPY | 4.41% |
2014 Q1 | 6.89 Billion JPY | 31.1% |
2014 Q2 | 7.4 Billion JPY | 7.37% |
2014 Q3 | 6.63 Billion JPY | -10.34% |
2013 Q2 | 6.33 Billion JPY | -14.43% |
2013 Q4 | 5.25 Billion JPY | -20.43% |
2013 FY | 25.59 Billion JPY | 10.26% |
2013 Q1 | 7.4 Billion JPY | 46.91% |
2013 Q3 | 6.6 Billion JPY | 4.36% |
2012 FY | 23.21 Billion JPY | 8.86% |
2012 Q2 | 5.87 Billion JPY | -2.92% |
2012 Q3 | 6.24 Billion JPY | 6.21% |
2012 Q4 | 5.03 Billion JPY | -19.33% |
2012 Q1 | 6.05 Billion JPY | 34.37% |
2011 Q4 | 4.5 Billion JPY | -16.35% |
2011 FY | 21.32 Billion JPY | 7.66% |
2011 Q1 | 6.07 Billion JPY | 60.1% |
2011 Q3 | 5.38 Billion JPY | 0.69% |
2011 Q2 | 5.35 Billion JPY | -11.98% |
2010 Q3 | 5.39 Billion JPY | -0.55% |
2010 Q1 | 5.18 Billion JPY | 47.75% |
2010 Q4 | 3.79 Billion JPY | -29.67% |
2010 FY | 19.8 Billion JPY | 32.66% |
2010 Q2 | 5.42 Billion JPY | 4.75% |
2009 Q4 | 3.5 Billion JPY | -18.04% |
2009 Q3 | 4.28 Billion JPY | 7.54% |
2009 Q2 | 3.98 Billion JPY | 0.0% |
2009 FY | 14.93 Billion JPY | 0.93% |
2008 FY | 14.79 Billion JPY | 1.85% |
2007 FY | 14.52 Billion JPY | 9.36% |
2006 FY | 13.28 Billion JPY | 0.0% |
2005 Q4 | - JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Bio Medica Corporation | -1.24 Million USD | -325423.349% |
Arrayit Corporation | -3.62 Million USD | -111507.451% |
Atlantic International Corp. | -5.73 Million USD | -70427.582% |
Biocept, Inc. | -31.98 Million USD | -12541.091% |
Bioqual, Inc. | -19.63 Thousand USD | -20587536.216% |
CardioGenics Holdings Inc | -772.14 Thousand USD | -523508.352% |
DermTech, Inc. | -103.73 Million USD | -3797.281% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 262.569% |
HTG Molecular Diagnostics, Inc. | -20.82 Million USD | -19309.882% |
iMD Companies, Inc. | -175.44 Thousand USD | -2304312.754% |
IDenta Corp. | -1499.00 USD | -269713042.095% |
Interpace Biosciences, Inc. | 2.8 Million USD | 144286.876% |
Integrative Health Technologies, Inc. | 38.69 Thousand USD | 10449828.612% |
InVitro International | -25.33 Thousand USD | -15955541.501% |
Lumos Diagnostics Holdings Limited | -7.12 Million USD | -56667.762% |
Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -6957154.956% |
Medical Imaging Corp. | -819.48 Thousand USD | -493261.644% |
NovelStem International Corp. | -3.52 Million USD | -114569.044% |
Optigenex Inc. | 1.39 Million USD | 290788.687% |
PharmChem, Inc. | 973.14 Thousand USD | 415556.247% |
Proteome Sciences plc | -1.62 Million USD | -249313.942% |
Response Genetics, Inc | -21.37 Million USD | -18812.85% |
Rennova Health, Inc. | -1.4 Million USD | -286732.386% |
RushNet, Inc. | -684.7 Thousand USD | -590373.27% |
ScreenPro Security Inc. | -2.59 Million USD | -155854.187% |
Stella Diagnostics Inc. | -11.42 Million USD | -35281.27% |
StageZero Life Sciences Ltd. | -7.74 Million USD | -52089.554% |
Todos Medical Ltd. | -9.74 Million USD | -41375.174% |